1084 A Radiomics-Based DeepSurv Model for Predicting Survival Outcomes in Patients With Brain Metastases

View at publisher Summarise with VIRAT
Authors: Mert Karabacak, Shiv Patil, Zachary Charles Gersey, Ricardo J. Komotar, Konstantinos D. Margetis
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: Predicting survival outcomes for brain metastasis (BM) patients is crucial for tailoring treatment strategies and improving patient management. Radiomics and deep learning (DL) approaches offer potential for non-invasive survival predictions. METHODS: This study utilized the Pretreat-MetsToBrain-Masks dataset, comprising of 199 patients. Radiomic features were extracted from four MRI sequences using PyRadiomics, yielding 4872 features per patient. Dimensionality reduction was performed using Principal Component Analysis, reducing the features to 71 principal components. In addition to radiomic features, demographic and clinical features were included.The data was split into training (70%) and test (30%) sets. A DL-based survival model, DeepSurv, was trained and evaluated. Overall model performance was assessed using C-index, integrated Brier score, and integrated negative binomial log-likelihood (NBLL) scores. Time-dependent performance metrics for predicting 1-year, 3-year, and 5-year survival were also calculated, including the area under the receiver operating characteristic curve (AUROC). RESULTS: The DeepSurv model demonstrated robust predictive capability. The overall model performance showed a test set C-index of 0.725, an integrated Brier score of 0.212, and an integrated NBLL score of 1.112. Time-dependent AUROC metrics were 0.793 for 1-year, 0.770 for 3-year, and 0.807 for 5-year survival predictions. CONCLUSIONS: This study presents a radiomics-based DL approach for predicting survival outcomes in patients with BM using pre-treatment MRI and clinical data. The promising results highlight the model’s potential as a non-invasive tool for personalized survival predictions.

Fields of Study & Subjects

Radiomics and Machine Learning in Medical Imaging Brain Metastases and Treatment Machine Learning in Healthcare

Publication details

Journal / source
Neurosurgery
Volume
72
Issue
Supplement_1
Pages
200–201
Publication date
26 March 2026
Language
EN